Boston Scientific Announces Upcoming Conference Schedule

MARLBOROUGH, Mass., Nov. 1, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor conferences.

On November 15, 2022, Dan Brennan, executive vice president and chief financial officer, and Lauren Tengler, vice president, Investor Relations, will participate in a 30-minute question-and-answer session with the host analyst at the 2022 Stifel Healthcare Conference. The session will begin at approximately 8:00 a.m. EST.

On November 30, 2022, Jeff Mirviss, executive vice president and president, Peripheral Interventions; Catherine Jennings, president, Peripheral Vascular; and Dr. Michael Jaff, vice president, Clinical Affairs, Innovation and Technology; and Lauren Tengler will participate in a 45-minute question-and-answer session with the host analyst for the 5th Annual Evercore ISI HealthCONx Conference. The session will begin at approximately 8:00 a.m. EST.

A live webcast and replay for each event will be accessible at The replays will be available beginning approximately one hour following the completion of each event.

About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit and connect on Twitter and Facebook.




Kate Haranis           

Lauren Tengler

508-683-6585 (office)   

508-683-4479 (office)

Media Relations             

Investor Relations

Boston Scientific Corporation   

Boston Scientific Corporation   


SOURCE Boston Scientific Corporation